Salix Names BioDelivery Sciences International CEO to Board

Posted: Feb 7, 2008

Raleigh, N.C. — Mark Sirgo, chief executive officer at BioDelivery Sciences International (Nasdaq: BDSI), is joining the board of directors at Salix Pharmaceuticals (Nasdaq: SLXP).

Sirgo is a graduate of Ohio State University with a degree in pharmacy. He earned a doctorate at the Philadelphia College of Pharmacy and Science. He has more than 25 years of experience in the pharmaceutical industry.

BDSI, which is based in the Triangle, is developing breakthrough pain treatments.

Salix, which is based in Raleigh, develops and sells a variety of gastrointestinal diseases.

Take WRAL.com to go

News Alerts to your Email & Cell Phone

Latest News
- AMD launches Yukon platform for ultraportable computers
  Posted at 2:09 p.m.
- Protecting your assets in tough economic times
  Updated at 2:01 p.m.
- Start a company in 2009 – Are you nuts? Well, no.
  Posted at 1:51 p.m.
- WRAL content now available through iPhone application
  Updated at 11:09 a.m. |
- Cisco joins backers for alternative to Microsoft Outlook
  Posted at 9:50 a.m.
more |

Venture/Innovation
- Global slowdown could trigger a ‘freeze’ in venture financing, Intersouth partner fears
  Updated at 11:34 a.m.
- Atlanta-based Indie Music rolls out popularity tool for musicians
  Posted at 6:50 a.m.
- How to survive nuclear winter? Seize the opportunity for success, says veteran S.C. exec
  Jan. 5, 2009
- VentureSource: Worst venture liquidity in five years
  Jan. 3, 2009
- High-tech headsets bring roar of NASCAR racing to videogames
  Jan. 2, 2009
more

Related Items

On The Web

Related Topics

Site Search

Salix Names BioDelivery Sciences International CEO to Board